CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Novo Nisk Adr Repsg 1 - NVO CFD

    128.52
    2.69%
    0.16
    Low: 126.36
    High: 128.62
    Market Trading Hours* (UTC) Opens on Wednesday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.16
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026179 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026179%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003957 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003957%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Novo Nordisk A/S ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 125.15
    Open* 126.36
    1-Year Change* -26.84%
    Day's Range* 126.36 - 128.62
    52 wk Range 65.59-108.98
    Average Volume (10 days) 4.22M
    Average Volume (3 months) 82.99M
    Market Cap 367.07B
    P/E Ratio 44.25
    Shares Outstanding 4.52B
    Revenue 31.29B
    EPS 2.43
    Dividend (Yield %) 0.47813
    Beta 0.41
    Next Earnings Date Jan 31, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 23, 2024 128.52 1.95 1.54% 126.57 128.70 126.26
    Apr 22, 2024 125.15 2.68 2.19% 122.47 126.19 122.47
    Apr 19, 2024 122.62 -0.73 -0.59% 123.35 124.46 122.29
    Apr 18, 2024 122.64 -0.64 -0.52% 123.28 124.02 122.45
    Apr 17, 2024 124.45 -0.44 -0.35% 124.89 125.12 123.15
    Apr 16, 2024 123.35 0.40 0.33% 122.95 124.17 121.69
    Apr 15, 2024 123.65 -2.03 -1.62% 125.68 125.98 123.43
    Apr 12, 2024 124.43 -2.19 -1.73% 126.62 126.98 124.22
    Apr 11, 2024 125.27 -0.26 -0.21% 125.53 125.71 124.08
    Apr 10, 2024 124.85 1.56 1.27% 123.29 125.19 123.22
    Apr 9, 2024 124.78 -1.24 -0.98% 126.02 126.64 124.13
    Apr 8, 2024 127.40 0.47 0.37% 126.93 127.51 125.92
    Apr 5, 2024 125.56 0.99 0.79% 124.57 126.09 124.50
    Apr 4, 2024 123.82 -2.96 -2.33% 126.78 127.39 123.50
    Apr 3, 2024 126.92 1.54 1.23% 125.38 128.05 125.28
    Apr 2, 2024 126.37 1.67 1.34% 124.70 126.61 124.02
    Apr 1, 2024 127.47 -1.49 -1.16% 128.96 128.96 127.07
    Mar 28, 2024 128.33 0.01 0.01% 128.32 130.07 127.61
    Mar 27, 2024 127.99 -0.32 -0.25% 128.31 128.57 127.22
    Mar 26, 2024 129.32 -0.54 -0.42% 129.86 129.91 128.35

    Novo Nisk Adr Repsg 1 Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 176954 140800 126946 122021 111831
    Revenue 176954 140800 126946 122021 111831
    Cost of Revenue, Total 28448 23658 20932 19559 17617
    Gross Profit 148506 117142 106014 102462 94214
    Total Operating Expense 102145 82156 72820 69538 64583
    Selling/General/Admin. Expenses, Total 49932 40409 36108 35301 33656
    Research & Development 21761 16292 13713 13477 13568
    Depreciation / Amortization 2478 1631 2178 856 1289
    Unusual Expense (Income) 809 714 477 1200 -6
    Other Operating Expenses, Total -1283 -548 -588 -855 -1541
    Operating Income 74809 58644 54126 52483 47248
    Interest Income (Expense), Net Non-Operating -5566 558 -846 -3757 439
    Other, Net -181 -122 -150 -173 -72
    Net Income Before Taxes 69062 59080 53130 48553 47615
    Net Income After Taxes 55525 47757 42138 38951 38628
    Net Income Before Extra. Items 55525 47757 42138 38951 38628
    Net Income 55525 47757 42138 38951 38628
    Income Available to Common Excl. Extra. Items 55525 47757 42138 38951 38628
    Income Available to Common Incl. Extra. Items 55525 47757 42138 38951 38628
    Dilution Adjustment
    Diluted Net Income 55525 47757 42138 38951 38628
    Diluted Weighted Average Shares 4544.6 4606.2 4680 4757.32 4848.83
    Diluted EPS Excluding Extraordinary Items 12.2178 10.368 9.00385 8.1876 7.96645
    Dividends per Share - Common Stock Primary Issue 5.55799 4.81518 3.96122 4.07135 4.1288
    Diluted Normalized EPS 12.3609 10.4933 9.08468 8.38996 7.96545
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 54300 53367 48092 45566 41265
    Revenue 54300 53367 48092 45566 41265
    Cost of Revenue, Total 7856 8182 8262 7200 6069
    Gross Profit 46444 45185 39830 38366 35196
    Total Operating Expense 30412 28360 31005 25382 22874
    Selling/General/Admin. Expenses, Total 15414 13483 15091 12609 11831
    Research & Development 7127 6728 8085 5633 5123
    Other Operating Expenses, Total 15 -33 -433 -60 -149
    Operating Income 23888 25007 17087 20184 18391
    Interest Income (Expense), Net Non-Operating 366 -270 -771 -2152 -1596
    Net Income Before Taxes 24254 24737 16316 18032 16795
    Net Income After Taxes 19428 19814 13592 14405 13318
    Net Income Before Extra. Items 19428 19814 13592 14405 13318
    Net Income 19428 19814 13592 14405 13318
    Income Available to Common Excl. Extra. Items 19428 19814 13592 14405 13318
    Income Available to Common Incl. Extra. Items 19428 19814 13592 14405 13318
    Diluted Net Income 19428 19814 13592 14405 13318
    Diluted Weighted Average Shares 4502.6 4513.2 4608.8 4537 4552.2
    Diluted EPS Excluding Extraordinary Items 4.31484 4.39023 2.94914 3.17501 2.92562
    Dividends per Share - Common Stock Primary Issue 4.0269 0 2.00676 0 3.62596
    Diluted Normalized EPS 4.31484 4.39023 2.94914 3.17501 2.92562
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 108194 85595 65809 62456 59067
    Cash and Short Term Investments 23116 16362 12104 14966 15638
    Cash 12195 9597 12104 14966 15638
    Short Term Investments 10921 6765
    Total Receivables, Net 57505 46799 32184 29152 24836
    Accounts Receivable - Trade, Net 50560 40643 27734 24912 22786
    Total Inventory 24388 19621 18536 17641 16336
    Prepaid Expenses 2053
    Other Current Assets, Total 3185 2813 2985 697 204
    Total Assets 241257 194508 144922 125612 110769
    Property/Plant/Equipment, Total - Net 66671 55362 50269 50551 41891
    Property/Plant/Equipment, Total - Gross 111426 95887 86686 84420 72438
    Accumulated Depreciation, Total -44755 -40525 -36417 -33869 -30547
    Intangibles, Net 46324 38825 20657 5835 5145
    Long Term Investments 886 1078 1348 1444 1296
    Note Receivable - Long Term 663 630 974 1205 477
    Other Long Term Assets, Total 13427 8672 5865 4121 2893
    Total Current Liabilities 120940 99516 70273 58983 54164
    Accounts Payable 15587 8870 5717 6358 6756
    Accrued Expenses 875 590 598 478 7015
    Notes Payable/Short Term Debt 480 12862 6684 659 515
    Other Current Liabilities, Total 103012 76372 56499 50673 39878
    Total Liabilities 157771 123762 81597 68019 58930
    Total Long Term Debt 24318 12961 2897 3009 0
    Deferred Income Tax 4685 5271 2502 80 118
    Other Liabilities, Total 7828 6014 5925 5947 4648
    Total Equity 83486 70746 63325 57593 51839
    Common Stock 456 462 470 480 490
    Retained Earnings (Accumulated Deficit) 80625 72934 63589 58291 54102
    Treasury Stock - Common -6 -6 -8 -10 -11
    Other Equity, Total 2411 -2644 -726 -1168 -2742
    Total Liabilities & Shareholders’ Equity 241257 194508 144922 125612 110769
    Total Common Shares Outstanding 3962.8 4015.07 4088 4167 4251
    Current Port. of LT Debt/Capital Leases 986 822 775 815
    Capital Lease Obligations 3543 3307 2897 3009
    Goodwill, Net 5092 4346
    Long Term Debt 20775 9654
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 142199 137551 113943 108194 119482
    Cash and Short Term Investments 47595 36408 27771 23574 37473
    Cash 30144 21574 14936 12653 28465
    Short Term Investments 17451 14834 12835 10921 9008
    Total Receivables, Net 61964 70521 57921 57505 53510
    Accounts Receivable - Trade, Net 52602 61294 50502 50560 45563
    Total Inventory 29534 28020 25615 24388 23222
    Other Current Assets, Total 3106 2602 2636 2727 5277
    Total Assets 300101 280753 250025 241257 242836
    Property/Plant/Equipment, Total - Net 81461 75024 70014 66671 63641
    Intangibles, Net 55726 50749 50489 51416 46924
    Long Term Investments 1471 1479 1211 1343 1239
    Note Receivable - Long Term 430 338 288 206 247
    Other Long Term Assets, Total 18814 15612 14080 13427 11303
    Total Current Liabilities 172552 156618 131961 120940 130257
    Accounts Payable 20106 17788 10050 15587 8310
    Notes Payable/Short Term Debt 0 0 0 480 0
    Current Port. of LT Debt/Capital Leases 6613 6289 1251 986 1833
    Other Current Liabilities, Total 145833 132541 120660 103887 120114
    Total Liabilities 207110 190280 170151 157771 166156
    Total Long Term Debt 19924 19415 24267 24318 24136
    Long Term Debt 19924 19415 24267 20775 24136
    Deferred Income Tax 7885 7627 7875 7061 5640
    Other Liabilities, Total 6749 6620 6048 5452 6123
    Total Equity 92991 90473 79874 83486 76680
    Common Stock 451 451 456 456 456
    Retained Earnings (Accumulated Deficit) 92545 90025 79424 80625 76228
    Treasury Stock - Common -5 -3 -6 -6 -4
    Total Liabilities & Shareholders’ Equity 300101 280753 250025 241257 242836
    Total Common Shares Outstanding 4523.62 3995.22 3960.95 3962.8 3955.07
    Capital Lease Obligations 3543
    Other Equity, Total 2411
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 55525 47757 42138 38951 38628
    Cash From Operating Activities 78887 55000 51951 46782 45028
    Cash From Operating Activities 7362 6025 5753 5661 3925
    Non-Cash Items 35847 24332 18841 16634 15085
    Cash Taxes Paid 14515 14438 10106 10936 9614
    Cash Interest Paid 272 261 422 204 89
    Changes in Working Capital -19847 -23114 -14781 -14464 -12610
    Cash From Investing Activities -24918 -31605 -22436 -11509 -12080
    Capital Expenditures -14753 -7385 -22081 -11231 -12410
    Other Investing Cash Flow Items, Total -10165 -24220 -355 -278 330
    Cash From Financing Activities -51797 -25493 -32244 -35484 -34521
    Total Cash Dividends Paid -25303 -21517 -20121 -19409 -19048
    Issuance (Retirement) of Stock, Net -24086 -19447 -16855 -15334 -15567
    Foreign Exchange Effects -238 591 -456 -7 44
    Net Change in Cash 1934 -1507 -3185 -218 -1529
    Issuance (Retirement) of Debt, Net -2408 15471 4732 -741 94
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 19814 55525 41933 27528 14210
    Cash From Operating Activities 29814 78887 71786 47547 23586
    Cash From Operating Activities 1719 7362 5327 3286 1650
    Non-Cash Items 25153 35847 39520 18991 11097
    Cash Taxes Paid 6679 14515 9928 8229 5260
    Cash Interest Paid 165 272 186 120 52
    Changes in Working Capital -16872 -19847 -14994 -2258 -3371
    Cash From Investing Activities -6647 -24918 -11068 -6107 -1907
    Capital Expenditures -4801 -14753 -8580 -4355 -1780
    Other Investing Cash Flow Items, Total -1846 -10165 -2488 -1752 -127
    Cash From Financing Activities -20621 -51797 -44129 -29566 -19135
    Financing Cash Flow Items 3393 2737
    Total Cash Dividends Paid -18337 -25303 -25303 -15690 -15690
    Issuance (Retirement) of Stock, Net -5199 -24086 -16547 -11927 -4477
    Issuance (Retirement) of Debt, Net -478 -2408 -2279 -1949 -1705
    Foreign Exchange Effects -263 -238 606 163 -55
    Net Change in Cash 2283 1934 17195 12037 2489

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Nordisk ADR Company profile

    Headquartered in Denmark, Novo Nordisk employs approximately 42,100 people in 79 countries and markets its products in more than 170 countries worldwide. The company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. Operating through two business segments, including diabetes and obesity care, and biopharmaceuticals. The company’s diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The company’s biopharmaceuticals segment covers the therapy areas of haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk’s insulin and other pharmaceutical products are marketed and distributed through subsidiaries, distributors and independent agents with responsibility for specific geographical areas. With Capital.com you stay in sync with the latest info on the Novo Nordisk (NVO) share price.
    Industry: Pharmaceuticals (NEC)

    Novo Alle 1
    BAGSVAERD
    2880
    DK

    Income Statement

    • Annual
    • Quarterly

    News

    We’re partnering with Newsquawk

    Filter out the noise and focus on the news that matters.

    08:32, 23 April 2024

    US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

    The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

    15:56, 22 April 2024

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    People also watch

    ETH/USD

    3,275.46 Price
    +1.770% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    Gold

    2,326.96 Price
    +0.200% 1D Chg, %
    Long position overnight fee -0.0193%
    Short position overnight fee 0.0111%
    Overnight fee time 21:00 (UTC)
    Spread 0.40

    BTC/USD

    67,076.80 Price
    +0.980% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    US100

    17,592.10 Price
    +0.430% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading